Health

Nerve stimulation for sleep apnea linked to lower diabetes and high blood pressure risk

A large percentage of adults with sleep apnea don’t use their CPAP, but untreated apnea is linked to heart attacks and other cardiovascular conditions

• November 16, 2026
A photograph of a woman sleeping in a yellow-lit room, taken from above
Surgery is not the first line of defense for sleep apnea patients. Sleep doctors say CPAP is considered gold standard. [Image Credit: Cottonbro Studio | Pexels]

A tiny device that sits below the tongue can help patients with sleep apnea breathe at night and is associated with better cardiovascular health, a recent study reports. 

Obstructive sleep apnea, which affects millions of Americans, is linked to diabetes and high blood pressure, researchers from the University of Chicago write in the study. Continuous positive airway pressure (CPAP) is the “gold standard” for treating sleep apnea, lead author Dr. Neil Kondamuri says. But somewhere between 30% and 60% of people with sleep apnea won’t use the device because they might get claustrophobic or a really dry mouth, he says.  

The researchers say a surgery called hypoglossal nerve stimulation, in which a pacemaker-like device keeps the tongue from blocking the airway, is another option. The procedure is covered by most insurance companies but could cost as much as $50,000 without coverage. 

The researchers compared about 7,000 patients who had filed insurance claims related to sleep apnea, half with the implant and half without. The data ranged from 2015, one year after the surgery was FDA-approved, to 2024. 

To the researchers’ surprise, the risk of a high blood pressure diagnosis within two years of surgery was higher for those with implants by 3 percentage points — 8.5% compared with 5.4% in the untreated group. Kondamuri chalks that finding up to more frequent medical visits, which increases the odds of a diagnosis. 

But after two years, fewer people developed diabetes: one in 50 with the implant compared with one in ten who were untreated. High blood pressure was a similar story. 

These results are suggestive, but preliminary, says Dr. Tucker Woodson, an expert in sleep medicine and surgery at the Medical College of Wisconsin, who has treated patients with the implant and was uninvolved with the study. 

Because the surgery is relatively new, the majority of implant patients had it within a year or two of 2024, so it’s impossible to know what their long-term health outcomes will be, Woodson says. 

For example, there was no association between the surgery and avoiding a heart attack or stroke, which Kondamuri says is expected because these conditions can take decades to play out. 

The study’s biggest limitation, Kondamuri says, is that the data don’t distinguish between cases of severe and mild sleep apnea in the untreated group. This is important, he says, because worse sleep apnea is associated with higher risks of diabetes and high blood pressure.

To address this, the researchers controlled for other factors associated with worse sleep apnea, such as BMI. Kondamuri says this mitigates their lack of data on sleep apnea severity. 

Jose Marin, a doctor of sleep medicine at the University of Zaragoza, says the study’s design limits its ability to link the surgery to cardiovascular outcomes. In an email, Marin writes that this research won’t encourage people to have the surgery while other effective therapies for sleep apnea are available. Nerve stimulation, he says, is expensive and associated with side effects. 

But Kondamuri clarified that “it is not a one-size-fits-all type treatment, and we know that there are patients that respond better to hypoglossal nerve stimulation and patients that don’t respond as well to hypoglossal nerve stimulation.”

Instead, Kondamuri hopes his team’s research will help other doctors determine when patients should consider the implant, or something similar, rather than remaining untreated. 

“Every patient who has sleep apnea should be trialed on a CPAP machine if it makes sense for them and makes sense for their life,” he adds. “Fingers crossed that [it] works because that is non-invasive compared to a surgical intervention.”

About the Author

Ann Whipple

Ann Whipple is a freelance journalist covering math, physics, and chemistry. With a background in “The Great Books,” Ann brings a philosophical eye to journalism and is drawn to complex, conceptual science stories.

Discussion

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe

The Scienceline Newsletter

Sign up for regular updates.